Vanderbilt University’s Guardant Health GH Stock Holding History

Vanderbilt University’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,726	Closed	-$994K	–	8
2019 Q4	$994K	Buy	+12,726	New	+$917K	0.36%	7

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanderbilt University's GH Position: Q1 2020 in Review

Vanderbilt University sold out of Guardant Health (GH) in Q1 2020, closing a stake of 12,726 shares — an estimated $994K sold.

Vanderbilt University first reported a position in GH in Q4 2019 and held it in 1 quarter. The position peaked at $994K in Q4 2019. 288 funds tracked by Wall St. Rank hold GH as of Q1 2020.

Vanderbilt University reported no remaining Guardant Health position as of Q1 2020 after selling out during the quarter.
Vanderbilt University sold 12,726 Guardant Health shares in Q1 2020, an estimated $994K.
Vanderbilt University first reported a position in Guardant Health in Q4 2019 and held it in 1 quarter.
Vanderbilt University's Guardant Health position peaked at $994K in Q4 2019.
288 funds tracked by Wall St. Rank held Guardant Health as of Q1 2020.

Based on Vanderbilt University's 13F filing for Q1 2020, filed 19 May 2023.